Aytu Biopharma (AYTU) Receivables - Net (2015 - 2026)
Aytu Biopharma's Receivables - Net came in at $22.78 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 26.9% from $31.16 million a year earlier and down 7.0% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Receivables - Net (2015 - 2026) Analysis & Trends
Going back to fiscal Q4 2015, Aytu Biopharma's Receivables - Net data covers 45 quarters.
- Receivables - Net carries a five-year compound annual growth rate of -4.2% (FY2021 to FY2026).
- Going back by fiscal year, Receivables - Net was $31.16 million in FY2025 (+32.4%), $23.53 million in FY2024 (-18.7%), $28.94 million in FY2023 (+33.3%) and $21.71 million in FY2022 (-22.9%).
- The fiscal Q4 2026 figure represents the lowest quarterly Receivables - Net since fiscal Q4 2022.
- Year-over-year, Receivables - Net increased in four of the last eight quarters, with growth averaging 2.8%.
- The fastest year-over-year change in Receivables - Net over five years came in fiscal Q1 2022 (growth of 253.8%), and the weakest in fiscal Q3 2026 (a decline of 31.6%).
- Business Quant data shows AYTU's Receivables - Net at $24.49 million (Q3 2026), $30.92 million (Q2 2026) and $33.23 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.78 Mn |
| Mar 31, 2026 | 24.49 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 33.23 Mn |
| Jun 30, 2025 | 31.16 Mn |
| Mar 31, 2025 | 35.83 Mn |
| Dec 31, 2024 | 25.40 Mn |
| Sep 30, 2024 | 23.16 Mn |
| Jun 30, 2024 | 23.53 Mn |
| Mar 31, 2024 | 29.93 Mn |
| Dec 31, 2023 | 29.40 Mn |
| Sep 30, 2023 | 29.90 Mn |
| Jun 30, 2023 | 28.94 Mn |
| Mar 31, 2023 | 34.04 Mn |
| Dec 31, 2022 | 25.55 Mn |
| Sep 30, 2022 | 27.92 Mn |
| Jun 30, 2022 | 21.71 Mn |
| Mar 31, 2022 | 27.61 Mn |
| Dec 31, 2021 | 22.99 Mn |
| Sep 30, 2021 | 21.63 Mn |
API Access
Aytu Biopharma Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();